Inventor · disambiguated record
Mac Arthur Johnson, Jr.
Also filed as: JOHNSON JR MAC ARTHUR
10 granted patents·7 pending applications·16 citations·filing 2019–2024
84Inventor score
Top patents by PatentIndex Score
17 records- 0192US11440907B1Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Sep 13, 2022·3 cites·25 claims
- 0291US11884672B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2020·Granted Jan 30, 2024·4 cites·11 claims
- 0389US12331057B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·1 cites·11 claims
- 0488US11059826B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2019·Granted Jul 13, 2021·3 cites·49 claims
- 0586US11572364B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2021·Granted Feb 7, 2023·1 cites·48 claims
- 0684US2025188070A1Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 0779US11623924B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2019·Granted Apr 11, 2023·3 cites·15 claims
- 0879US10815225B2Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Oct 27, 2020·1 cites·50 claims
- 0977US12195453B2Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2022·Granted Jan 14, 2025·0 cites·24 claims
- 1076US12384790B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2022·Granted Aug 12, 2025·0 cites·20 claims
- 1168US2023265080A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1254US12502376B2Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)VERTEX PHARMA·Filed 2021·Granted Dec 23, 2025·0 cites·33 claims
- 1353US2023159502A1Indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1453US2023339915A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1553US2023159504A17- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1652US2023159580A1Pyrrolo[2,3-f]indazole and 2,4,5,10-tetrazatricyclo[7.3.0.03,7]dodeca-1,3(7),5,8,11-pentaene derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1752US2023159521A11h-pyrazolo[4,3-g]isoquinoline and 1h-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mac Arthur Johnson, Jr. files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →